Skip to pipeline

Our Story

About us

Our Mission

To build technologies that make medicines programmable, scalable, and accessible to humanity with the purpose of extending healthy life to every person born with, living with, or at risk of disease.

The rapid emergence of Advanced Biology and AI intensifies the urgency of our mission, as it has the potential to accelerate not only the design of new medicines, but also the transformation of human health itself.

The full promise of our technologies will depend on building an integrated platform that can convert biological insight into safe, precise, scalable, and widely accessible therapies. Micro CRISPR exists to build that platform.​

Micro CRISPR DNA structure

History

The Bilakhia Group Journey

Over the past three decades, The Bilakhia Group has worked towards accelerating technologies over various fronts. From spearheading the printing inks and agrochemical sectors to becoming one of the largest medical device companies in Asia. We enjoy being at the forefront of technology and continuously investing ahead of the curve to create innovative solutions that have a tangible impact on society. Micro CRISPR is the latest endeavour in our journey to leave a lasting impact.

From the floor

01 / 06

Precision. Purity. Progress.
Where Biology Becomes Therapy
Built for Safety. Designed for Impact.
Scale without leaving the building
Scale without leaving the building
Scale without leaving the building

OUR IMPACT

Building the Future of Medicine

0

Years of Innovation

0

Therapy Near Approval

0

Clinical Asset

0

IND Assets

0

Disease Areas

0

Modalities

0+

Total Team

0+

Programs in Pipeline